Introduction: Chylous effusions are rare and their etiologies are multiple and diverse. Chylothorax is the most common; however, chylopericardium is exceptional. The aim of this work is to report the epidemiological, diagnostic and therapeutic aspects of Hodgkin lymphoma revealed by chylopericardium and bilateral chylothorax with review of the literature. Case presentation: It’s about a 34 years old man, with no particular pathological history, admitted in emergency, with a cardiac tamponade associated with a bilateral pleural effusion. The patient underwent a subxiphoid pericardiostomy and pleural drainage, removing milky pericardial (800cc) and pleural (1850cc) fluid. Fluid analysis confirmed a chylous effusion with no malignant cells. The patient was started on a low dietary fat diet which allowed a decrease in the chyle output after 10 days. A mediastinal mass biopsy was performed, through an anterior right mediastinotomy, revealing a Hodgkin lymphoma. The patient was referred to an Oncology center and underwent a full course of chemotherapy. The patient’s response to chemotherapy was favorable with a good clinical outcome and complete regression of the superior vena cava syndrome, the edema and the respiratory distress. Conclusion: It’s important to keep in mind some uncommon presentations of mediastinal tumors in general, and specifically Hodgkin Lymphoma; as well as the role of the 3 cornerstones (low-fat diet, surgery, and treatment of the underlying cause) in the management of this condition.
Published in | International Journal of Cardiovascular and Thoracic Surgery (Volume 9, Issue 3) |
DOI | 10.11648/j.ijcts.20230903.13 |
Page(s) | 32-35 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Chylopericardium, Chylothorax, Lymphoma, Mediastinal Tumor
[1] | Dib C, Tajik AJ, Park S, Kheir MEL, Khandieria B, Mookadam F. Chylopericardium in adults: A literature review over the past decade (1996-2006). J Thorac Cardiovasc Surg. 2008; 136 (3): 650-656. doi: 10.1016/j.jtcvs.2008.03.033. |
[2] | N Milandt, T Birkelund M Engholm Acute Chylopericardium with Tamponnade and Cardiac Arrest with pseudomyxoma Peritonei. Am J Cardiol 2021; 146: 134-136. |
[3] | Wijaya S Y, Koesoemoprodjo W Indonesian female with bilateral chylothorax and mediastinal non-Hodgkin lymphoma: a case report. Int J Surg Case Report. 2023 Jan; 102: 107827. doi: 10.1016/j.ijscr.2022.107827. |
[4] | Petrini M, Colombi D, Bodini F G and al Thoracic duct leakage in a patient with Type B-Non-Hodgkin lymphoma treated with transvenous retrograde access embolization: a case report. Acta Biomed 2023 Jan 31; 94 (S1): e2023043. doi: 10.23750/abm.v94iS1.12732. |
[5] | Doerr CH, Allen MS, Nichols FC, Ryu JH. Etiology of chylothorax in 203 patients. Mayo Clin Proc. 2005; 80 (7): 867-870. doi: 10.4065/80.7.867. |
[6] | Rochefort MM. Review of chylopericardium. Mediastinum. 2022; 6: 6-10. doi: 10.21037/MED-20-64. |
[7] | O’donnell J, Kirkham J, Monteith D, Frontario C, Sharma R, Higgins B. Chylous Cardiac Tamponade with Chylothoraces Secondary to Hodgkin’s Lymphoma: Octreotide in Conjuncture with Standard of Care Dietary Fat Restriction. Case Reports Crit Care. 2019; 2019: 6-9. doi: 10.1155/2019/1406840. |
[8] | Verma SK, Karmakar S. Hodgkin’s lymphoma presenting as chylothorax. Lung India. 2014; 31 (2): 184-186. doi: 10.4103/0970-2113.129883. |
[9] | Mehrotra S, Peeran NA, Brandyopadhay A. Idiopathic chylopericardium: an unusual cause of cardiac tamponade. Tex Heart Inst J. 2006; 33 (2): 249-52. |
[10] | Alsagaff MY, Laksmi NPA, Maghfirah I, Susilo H. Tamponade with recurrent chylopericardium in patient with non-Hodgkin's lymphoma: chemotherapy is the key management after pericardiocentesis. BMJ Case Rep. 2022 May 17; 15 (5): e249675. doi: 10.1136/bcr-2022-249675. |
[11] | Bender B, Murthy V, Chamberlain RS. The changing management of chylothorax in the modern era. Eur J Cardio-thoracic Surg. 2016; 49 (1): 18-24. doi: 10.1093/ejcts/ezv041. |
[12] | Janjetovic S, Janning M, Daukeva L and al Chylothorax in a patient with Hodgkin's lymphoma: a case report and review of the literature. Tumori 2013 May-Jun; 99 (3): e96-9. doi: 10.1177/030089161309900324. |
[13] | O’Callaghan AM, Mead GM Chylothorax in lymphoma: Mechanisms and management. Ann Oncol, 1995; 6: 603-607. |
[14] | Gurevich A, Hur S, Singhal S, DiBardino D, Haas AR, Hansen-Flaschen JH, Nadolski G, Itkin M. Nontraumatic Chylothorax and Chylopericardium: Diagnosis and Treatment Using an Algorithmic Approach Based on Novel Lymphatic Imaging. Ann Am Thorac Soc. 2022 May; 19 (5): 756-762. doi: 10.1513/AnnalsATS.202103-262OC. |
[15] | M V Pulle, H V Puri, B B Asaf and al Chylothorax - Modalities of management and outcomes: A case series. Lung India. 2021 Mar-Apr; 38 (2): 154–160. doi: 10.4103/lungindia.lungindia_526_20. |
[16] | Dori Y, Zviman MM, Itkin M. Dynamic contrast-enhanced MR lymphangiography: feasibility study in swine. Radiology 2014; 273: 410–416. https://doi.org/10.1148/radiol.14132616 |
APA Style
Papa Ousmane Ba, Myriam Bizrane, Souleymane Diatta, Jean Claude Ndiogou Dione, Momar Sokhna Diop, et al. (2023). Chylopericardium with Chylothorax as an Unusual Presentation of Hodgkin Lymphoma. International Journal of Cardiovascular and Thoracic Surgery, 9(3), 32-35. https://doi.org/10.11648/j.ijcts.20230903.13
ACS Style
Papa Ousmane Ba; Myriam Bizrane; Souleymane Diatta; Jean Claude Ndiogou Dione; Momar Sokhna Diop, et al. Chylopericardium with Chylothorax as an Unusual Presentation of Hodgkin Lymphoma. Int. J. Cardiovasc. Thorac. Surg. 2023, 9(3), 32-35. doi: 10.11648/j.ijcts.20230903.13
AMA Style
Papa Ousmane Ba, Myriam Bizrane, Souleymane Diatta, Jean Claude Ndiogou Dione, Momar Sokhna Diop, et al. Chylopericardium with Chylothorax as an Unusual Presentation of Hodgkin Lymphoma. Int J Cardiovasc Thorac Surg. 2023;9(3):32-35. doi: 10.11648/j.ijcts.20230903.13
@article{10.11648/j.ijcts.20230903.13, author = {Papa Ousmane Ba and Myriam Bizrane and Souleymane Diatta and Jean Claude Ndiogou Dione and Momar Sokhna Diop and Papa Amath Diagne and Kondo Bignandi and Mory Camara and Marème Soda Mbaye and Papa Adama Dieng and Amadou Gabriel Ciss and Assane Ndiaye}, title = {Chylopericardium with Chylothorax as an Unusual Presentation of Hodgkin Lymphoma}, journal = {International Journal of Cardiovascular and Thoracic Surgery}, volume = {9}, number = {3}, pages = {32-35}, doi = {10.11648/j.ijcts.20230903.13}, url = {https://doi.org/10.11648/j.ijcts.20230903.13}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcts.20230903.13}, abstract = {Introduction: Chylous effusions are rare and their etiologies are multiple and diverse. Chylothorax is the most common; however, chylopericardium is exceptional. The aim of this work is to report the epidemiological, diagnostic and therapeutic aspects of Hodgkin lymphoma revealed by chylopericardium and bilateral chylothorax with review of the literature. Case presentation: It’s about a 34 years old man, with no particular pathological history, admitted in emergency, with a cardiac tamponade associated with a bilateral pleural effusion. The patient underwent a subxiphoid pericardiostomy and pleural drainage, removing milky pericardial (800cc) and pleural (1850cc) fluid. Fluid analysis confirmed a chylous effusion with no malignant cells. The patient was started on a low dietary fat diet which allowed a decrease in the chyle output after 10 days. A mediastinal mass biopsy was performed, through an anterior right mediastinotomy, revealing a Hodgkin lymphoma. The patient was referred to an Oncology center and underwent a full course of chemotherapy. The patient’s response to chemotherapy was favorable with a good clinical outcome and complete regression of the superior vena cava syndrome, the edema and the respiratory distress. Conclusion: It’s important to keep in mind some uncommon presentations of mediastinal tumors in general, and specifically Hodgkin Lymphoma; as well as the role of the 3 cornerstones (low-fat diet, surgery, and treatment of the underlying cause) in the management of this condition.}, year = {2023} }
TY - JOUR T1 - Chylopericardium with Chylothorax as an Unusual Presentation of Hodgkin Lymphoma AU - Papa Ousmane Ba AU - Myriam Bizrane AU - Souleymane Diatta AU - Jean Claude Ndiogou Dione AU - Momar Sokhna Diop AU - Papa Amath Diagne AU - Kondo Bignandi AU - Mory Camara AU - Marème Soda Mbaye AU - Papa Adama Dieng AU - Amadou Gabriel Ciss AU - Assane Ndiaye Y1 - 2023/06/27 PY - 2023 N1 - https://doi.org/10.11648/j.ijcts.20230903.13 DO - 10.11648/j.ijcts.20230903.13 T2 - International Journal of Cardiovascular and Thoracic Surgery JF - International Journal of Cardiovascular and Thoracic Surgery JO - International Journal of Cardiovascular and Thoracic Surgery SP - 32 EP - 35 PB - Science Publishing Group SN - 2575-4882 UR - https://doi.org/10.11648/j.ijcts.20230903.13 AB - Introduction: Chylous effusions are rare and their etiologies are multiple and diverse. Chylothorax is the most common; however, chylopericardium is exceptional. The aim of this work is to report the epidemiological, diagnostic and therapeutic aspects of Hodgkin lymphoma revealed by chylopericardium and bilateral chylothorax with review of the literature. Case presentation: It’s about a 34 years old man, with no particular pathological history, admitted in emergency, with a cardiac tamponade associated with a bilateral pleural effusion. The patient underwent a subxiphoid pericardiostomy and pleural drainage, removing milky pericardial (800cc) and pleural (1850cc) fluid. Fluid analysis confirmed a chylous effusion with no malignant cells. The patient was started on a low dietary fat diet which allowed a decrease in the chyle output after 10 days. A mediastinal mass biopsy was performed, through an anterior right mediastinotomy, revealing a Hodgkin lymphoma. The patient was referred to an Oncology center and underwent a full course of chemotherapy. The patient’s response to chemotherapy was favorable with a good clinical outcome and complete regression of the superior vena cava syndrome, the edema and the respiratory distress. Conclusion: It’s important to keep in mind some uncommon presentations of mediastinal tumors in general, and specifically Hodgkin Lymphoma; as well as the role of the 3 cornerstones (low-fat diet, surgery, and treatment of the underlying cause) in the management of this condition. VL - 9 IS - 3 ER -